List of Quest Diagnostics patents

Patents where

Current Assignee

Name

Quest Diagnostics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11345964 BCR-ABL truncation mutations		Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11345964	May 31, 2022
‌ US Patent 11466325 Method to detect repeat sequence motifs in nucleic acid		Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11466325	October 11, 2022
‌ US Patent 11441188 Methods for detecting DNA mutations using Mitra tip extraction		Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11441188	September 13, 2022
‌ US Patent 11441192 Methods for detecting DNA mutations using mitra tip extraction		Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11441192	September 13, 2022
‌ US Patent 10324082 Methods for quantitation of insulin levels by mass spectrometry	Patent 10324082 was granted and assigned to Quest Diagnostics on June, 2019 by the United States Patent and Trademark Office.	Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	10324082	June 18, 2019
‌ US Patent 11275088 BCR-ABL variants	Patent 11275088 was granted and assigned to Quest Diagnostics on March, 2022 by the United States Patent and Trademark Office.	Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11275088	March 15, 2022
‌ US Patent 11555223 Methods for detecting Norovirus		Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11555223	January 17, 2023
‌ US Patent 11473144 Methods for detecting cystic fibrosis mutations using mitra tip extraction		Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11473144	October 18, 2022
‌ US Patent 11486005 Methods for detecting cystic fibrosis mutations using mitra tip extraction	Patent 11486005 was granted and assigned to Quest Diagnostics on November, 2022 by the United States Patent and Trademark Office.	Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11486005	November 1, 2022
‌ US Patent 11278904 Container for a specimen and method of using same	Patent 11278904 was granted and assigned to Quest Diagnostics on March, 2022 by the United States Patent and Trademark Office.	Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11278904	March 22, 2022
‌ US Patent 10982288 Methods of detecting MLH1 methylation	Patent 10982288 was granted and assigned to Quest Diagnostics on April, 2021 by the United States Patent and Trademark Office.	Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	10982288	April 20, 2021
‌ US Patent 11360098 Amyloid beta detection by mass spectrometry	Patent 11360098 was granted and assigned to Quest Diagnostics on June, 2022 by the United States Patent and Trademark Office.	Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11360098	June 14, 2022
‌ US Patent 10226120 Workspace for performing liquid chromotography analysis	Patent 10226120 was granted and assigned to Quest Diagnostics on March, 2019 by the United States Patent and Trademark Office.	Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	10226120	March 12, 2019
‌ US Patent 11447826 Cystic fibrosis transmembrane conductance regulator gene mutations		Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11447826	September 20, 2022
‌ US Patent 11639529 EML4-ALK translocations in lung cancer	Patent 11639529 was granted and assigned to Quest Diagnostics on May, 2023 by the United States Patent and Trademark Office.	Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11639529	May 2, 2023
‌ US Patent 11421283 Circulating microRNA as a marker for hepatocellular carcinoma		Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11421283	August 23, 2022
‌ US Patent 11085079 Universal Sanger sequencing from next-gen sequencing amplicons	Patent 11085079 was granted and assigned to Quest Diagnostics on August, 2021 by the United States Patent and Trademark Office.	Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11085079	August 10, 2021
‌ US Patent 11414710 Compositions and methods for detecting circulating tumor DNA	Patent 11414710 was granted and assigned to Quest Diagnostics on August, 2022 by the United States Patent and Trademark Office.	Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11414710	August 16, 2022
‌ US Patent 11231401 Methods for detecting chromogranin a by mass spectrometry	Patent 11231401 was granted and assigned to Quest Diagnostics on January, 2022 by the United States Patent and Trademark Office.	Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11231401	January 25, 2022
‌ US Patent 11499199 Bordetella detection assay			Quest Diagnostics	United States Patent and Trademark Office	11499199	November 15, 2022
‌ US Patent 10983108 Methods for quantitation of insulin and C-peptide	Patent 10983108 was granted and assigned to Quest Diagnostics on April, 2021 by the United States Patent and Trademark Office.		Quest Diagnostics	United States Patent and Trademark Office	10983108	April 20, 2021
‌ US Patent D922611 Plate for a sampling apparatus	Patent D922611 was granted and assigned to Quest Diagnostics on June, 2021 by the United States Patent and Trademark Office.	Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	D922611	June 15, 2021
‌ US Patent 11398295 System and method for classification of patients	Patent 11398295 was granted and assigned to Quest Diagnostics on July, 2022 by the United States Patent and Trademark Office.	Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11398295	July 26, 2022
‌ US Patent 11021758 Methods for detecting gene dysregulation by intragenic differential expression	Patent 11021758 was granted and assigned to Quest Diagnostics on June, 2021 by the United States Patent and Trademark Office.	Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11021758	June 1, 2021
‌ US Patent 11118232 Methods of detecting DDR2 mutations	Patent 11118232 was granted and assigned to Quest Diagnostics on September, 2021 by the United States Patent and Trademark Office.	Quest Diagnostics	Quest Diagnostics	United States Patent and Trademark Office	11118232	September 14, 2021

Results per page:

48 results

0 selected

48 results

0 selected